Clinical trial

XELOX for Metastatic Breast Cancer

NCT00204776

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-03-01

PhasePHASE2

Study timeline

Study start (unknown)2005-03-01Date precision: month

Registry last updated2019-12-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Interventions

Capecitabine and OxaliplatinDRUG

Sponsors & collaborators

University of Wisconsin, Madisonlead sponsor

Sanoficollaborator

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00204776 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.